
Two New Patents Granted to Lexaria for Revolutionary Dehydratech Technology: A Game-Changer in Epilepsy Treatment!
Lexaria Bioscience’s New Patents: A Game-Changer for Epilepsy Treatment Kelowna, BC – In a groundbreaking development, Lexaria Bioscience Corp. (LEXX, LEXXW) has announced the granting of two new patents by the United States Patent and Trademark Office (USPTO) for the application of its proprietary DehydraTECH™ technology in the treatment of epilepsy. This marks a significant…